BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Ariad Pharmaceuticals, Inc. Announces Preliminary Safety And Efficacy Data Of Ponatinib In Patients With Newly Diagnosed CML From Discontinued Phase 3 EPIC Trial

  June 2, 2014

   · 

  1 min read
• Drug Development

  Immunomedics, Inc. Reports Final Efficacy Results Of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan In Patients With Metastatic Pancreatic Cancer

  June 2, 2014

   · 

  1 min read
• Drug Development

  Tesaro, Inc. Summarizes Phase 3 Rolapitant Data Presented At The 2014 American Society of Clinical Oncology Annual Meeting And Provides An Update On Niraparib Development Strategy

  June 2, 2014

   · 

  1 min read
• Drug Development

  Nanobiotix Presents Successful Phase I Results For Its Lead Nanomedicine Product NBTXR3 At American Society of Clinical Oncology

  June 2, 2014

   · 

  1 min read
• Business

  Ipca Laboratories And Oncobiologics Inc. Create Strategic Biosimilars Partnership

  June 2, 2014

   · 

  3 min read
• Business

  William Gerber, MD. Appointed CEO At SynGen Inc.

  June 2, 2014

   · 

  3 min read
• CardioMEMS Acquired By St. Jude Medical

  June 2, 2014

   · 

  3 min read
• MediWound To Present At Jefferies and Co. 2014 Global Healthcare Conference

  June 2, 2014

   · 

  1 min read
• Drug Development

  Scancell: Update On Phase 1/2 Clinical Trial Of SCIB1 In Stage III/IV Melanoma

  June 2, 2014

   · 

  10 min read
• Business

  Sarepta Therapeutics Opens New Global Headquarters In Cambridge, Mass.

  June 2, 2014

   · 

  1 min read